Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
255.00
Ask:
265.00
Spread: 10.00 (3.922%)
Market Cap: £236.19m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Post-Close Trading Update

5 Jan 2022 07:00

RNS Number : 4303X
Concurrent Technologies PLC
05 January 2022
 

 

5 January 2022

 

Concurrent Technologies Plc

(the 'Company')

 

Post-Close Trading Update

 

Concurrent Technologies Plc (AIM: CNC), a world leading specialist in high-end embedded computer products for critical applications, announces a trading update for the year ending 31 December 2021.

 

Based on its unaudited management accounts for 2021, the Company expects to report revenues and profitability slightly ahead of market expectations despite the ongoing challenges that the worldwide component supply chain is experiencing. Whilst the component issues are ongoing, the Company enters 2022 with a robust order book and an exciting pipeline of innovative product releases to grow our customer base and revenues in 2022 and beyond.

 

The Company also expects to pay a final dividend to shareholders and to pay this after the final results for 2021 are announced.

 

 

Dr Miles Adcock commented: 

 

"I am delighted with the 2021 trading performance, in particular how the experienced management team and dedicated staff enabled Concurrent to minimise impact of the global supply chain issues, and I am confident in the long term prospects for the business."

 

Enquiries:

 

Concurrent Technologies PlcMiles Adcock - CEO

Jonathan Martin - CFO

 

+44 (0)1206 752626

+44 (0)1206 635585

 

 

Newgate (Financial PR)Bob Huxford

Isabelle Smurfit

 

+44 (0)20 7653 9848+44 (0)20 3757 3411

 

 

Cenkos Securities Plc (NOMAD)Neil McDonald

Peter Lynch

+44 (0)131 220 9771

+44 (0)131 220 9772

 

Note to Editors:

 

About Concurrent Technologies Plc

 

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high-performance, long-life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest 11th generation embedded Intel® Core™, Intel® Xeon® and Intel Atom® processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems. The products are sold world-wide.

 

For more information on Concurrent Technologies Plc and its products please visit www.gocct.com.

 

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUSSWRUBUARAR
Date   Source Headline
6th Sep 20187:00 amRNSNotification of Interim Results
8th Jun 20187:00 amRNSProduct Announcement
22nd May 20183:41 pmRNSAGM Statement
21st May 20187:00 amRNSProduct Announcement
30th Apr 20189:30 amRNSDistribution of Annual Report and Accounts
4th Apr 20187:00 amRNSResults for the year ended 31 December 2017
3rd Apr 20189:01 amRNSProduct Announcement
28th Mar 20184:03 pmRNSNotice of Results
27th Mar 20182:14 pmRNSProduct Announcement
8th Mar 20187:00 amRNSSecond Interim Dividend
26th Feb 201810:17 amRNSCorrection - Product Announcement
26th Feb 20187:00 amRNSProduct Announcement
21st Feb 20187:00 amRNSProduct Announcement
23rd Jan 20187:00 amRNSProduct Announcement
21st Dec 20177:00 amRNSPre-Close Trading Update
30th Nov 20171:29 pmRNSProduct Announcement
18th Sep 20177:00 amRNSInterim Results for the six months ended 30 Jun 17
5th Sep 20177:00 amRNSNotice of Results
26th Jun 20177:00 amRNSProduct Announcement
25th May 20172:57 pmRNSResult of AGM
9th May 20177:00 amRNSNotice of AGM
12th Apr 20172:08 pmRNSDistribution of Annual Report and Accounts
30th Mar 201711:18 amRNSHolding(s) in Company
29th Mar 20174:33 pmRNSHolding(s) in Company
24th Mar 20177:00 amRNSFinal Results
22nd Mar 20177:00 amRNSNotice of Results
2nd Mar 201710:11 amRNSProduct Announcement
24th Feb 20177:00 amRNSSecond Interim Dividend
30th Jan 20179:23 amRNSProduct Announcement
13th Jan 20179:30 amRNSHolding(s) in Company
13th Jan 20179:30 amRNSHolding(s) in Company
20th Dec 20162:36 pmRNSPre-Close Trading Update
16th Dec 20163:13 pmRNSDirector/PDMR Shareholding
1st Nov 20167:00 amRNSProduct Launch
29th Sep 20167:00 amRNSProduct Launch
22nd Sep 20162:45 pmRNSTotal Voting Rights
9th Sep 201612:05 pmRNSDirector/PDMR Shareholding
30th Aug 20165:05 pmRNSHolding(s) in Company
30th Aug 201612:59 pmRNSHolding(s) in Company
26th Aug 20167:00 amRNSInterim Results
19th Aug 20162:21 pmRNSNotice of Interim Results
22nd Jul 20161:55 pmRNSHolding(s) in Company
1st Jul 20167:00 amRNSTrading Update
1st Jun 20162:43 pmRNSTotal Voting Rights
19th May 201612:56 pmRNSAGM Statement
12th May 20165:18 pmRNSDirector/PDMR Shareholding
6th May 20167:00 amRNSProduct Launch
19th Apr 20163:51 pmRNSDirector/PDMR Shareholding
19th Apr 201612:10 pmRNSDirector/PDMR Shareholding
18th Apr 20162:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.